Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly.

Abstract : BACKGROUND: We evaluated if plasma β-amyloid (Aβ) levels were associated with mortality risks in a subsample of the French Three-City (3C) prospective cohort study. METHODS: Analyses were based on 1254 participants randomly selected from the initial 3C cohort stratified by center, sex, and age in the context of a nested case-cohort study to investigate biological variables. Associations between plasma Aβ and mortality were assessed with the Cox regression model with delayed entry including various potential confounding factors and testing possible mediators. RESULTS: A relationship between high plasma Aβ1-40 concentrations and risk of mortality (hazards ratio, 1.15; 95% confidence interval, 1.01-1.31, P = .03) was unveiled independently of age, educational level, vascular risk factors, diet, physical activity, cognitive impairment, or frailty status. It was only modified when we included cystatin C levels. CONCLUSIONS: Further investigations are needed to determine precisely the pathophysiological roles of plasma Aβ1-40 and cystatin C and before envisioning any future clinical applications.
Type de document :
Article dans une revue
Alzheimer's and Dementia, Elsevier, 2015, 11 (6), pp.672-80. 〈10.1016/j.jalz.2014.04.515〉
Liste complète des métadonnées

Littérature citée [38 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01024830
Contributeur : Claudine Berr <>
Soumis le : mercredi 16 juillet 2014 - 17:12:41
Dernière modification le : lundi 8 octobre 2018 - 17:44:04
Document(s) archivé(s) le : lundi 24 novembre 2014 - 16:52:12

Fichier

Gabelle_Alz_Dem_2014_Plasma_Ab...
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Audrey Gabelle, Susanna Schraen, Laure-Anne Gutierrez, Cecile Pays, Olivier Rouaud, et al.. Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly.. Alzheimer's and Dementia, Elsevier, 2015, 11 (6), pp.672-80. 〈10.1016/j.jalz.2014.04.515〉. 〈inserm-01024830〉

Partager

Métriques

Consultations de la notice

4306

Téléchargements de fichiers

656